within Pharmacolibrary.Drugs.L_AntineoplasticAndImmunomodulatingAgents.L01A_AlkylatingAgents.L01AA03_Melphalan;

model Melphalan
  extends Pharmacolibrary.Drugs.ATC.L.L01AA03;

  annotation (Documentation(
info       = "<html><body><table><tr><td>Drug:</td><td>L01AA03</td></tr><td>route:</td><td>intravenous</td></tr><tr><td>n-compartments</td><td>2</td></tr></table><p>Melphalan is an alkylating agent used in the treatment of multiple myeloma and ovarian cancer. It works by cross-linking DNA, thus inhibiting DNA and RNA synthesis and leading to cell death. It is still approved and in clinical use, particularly for hematological malignancies.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters derived from adult patients with multiple myeloma receiving intravenous melphalan for conditioning therapy prior to stem cell transplantation.</p><h4>References</h4><ol><li><p>Barta, SK, et al., &amp; Braunschweig, I (2017). Pharmacokinetics-directed Intravenous Busulfan Combined With High-dose Melphalan and Bortezomib as a Conditioning Regimen for Patients With Multiple Myeloma. <i>Clinical lymphoma, myeloma &amp; leukemia</i> 17(10) 650–657. DOI:<a href=&quot;https://doi.org/10.1016/j.clml.2017.06.005&quot;>10.1016/j.clml.2017.06.005</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/28684379/&quot;>https://pubmed.ncbi.nlm.nih.gov/28684379</a></p></li><li><p>Pinguet, F, et al., &amp; Bressolle, F (1997). Pharmacokinetics of high-dose intravenous melphalan in patients undergoing peripheral blood hematopoietic progenitor-cell transplantation. <i>Anticancer research</i> 17(1B) 605–611. PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/9066587/&quot;>https://pubmed.ncbi.nlm.nih.gov/9066587</a></p></li><li><p>Koltun, M, et al., &amp; McIntosh, MP (2010). Preclinical comparison of intravenous melphalan pharmacokinetics administered in formulations containing either (SBE)7 m-β-cyclodextrin or a co-solvent system. <i>Biopharmaceutics &amp; drug disposition</i> 31(8-9) 450–454. DOI:<a href=&quot;https://doi.org/10.1002/bdd.725&quot;>10.1002/bdd.725</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/20865695/&quot;>https://pubmed.ncbi.nlm.nih.gov/20865695</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>",
    experiment (StartTime = 0, StopTime = 86400, Tolerance = 1e-9, Interval = 1)
  ));
end Melphalan;
